FIELD: biotechnology.
SUBSTANCE: present invention relates to biotechnology and discloses a polypeptide containing a fragment of high-mobility group protein B1 (HMGB1).
EFFECT: invention demonstrates the effect of restoration / regeneration of cartilage tissue, which can be used in medicine in the treatment of hyaline cartilage diseases or their prevention.
18 cl, 8 dwg, 2 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
SCHEME FOR USING FGF-18 COMPOUND | 2015 |
|
RU2691946C2 |
IMPLANT CONTAINING FGF-18 | 2015 |
|
RU2700414C2 |
SCHEME FOR USING FGF-18 COMPOUND | 2015 |
|
RU2700582C2 |
FGF-18 IN TRANSPLANTATION AND TISSUE ENGINEERING PROCEDURES | 2015 |
|
RU2682159C2 |
COMBINED COMPOSITION CONTAINING FGF-18 COMPOUND | 2016 |
|
RU2745453C2 |
APPLICATION OF GROWTH HORMONE FRAGMENTS | 2012 |
|
RU2639474C2 |
NEW PEPTIDE AND ITS APPLICATION | 2011 |
|
RU2525913C1 |
FGF-18 COMPOSITION IN XYLOGLUCAN GELS | 2014 |
|
RU2695343C2 |
THERAPEUTIC AGENT FOR THE TREATMENT OF CARDIOMYOPATHY, PREVIOUS MYOCARDIAL INFARCTION AND CHRONIC HEART FAILURE | 2018 |
|
RU2795320C2 |
THERAPEUTIC OR PREVENTIVE DRUG FOR TREATING OSTEOARTHRITIS | 2009 |
|
RU2492871C2 |
Authors
Dates
2024-02-19—Published
2019-10-25—Filed